DFX Intelligence

Data Factory

VentureFirmmulti stage vc · probableregistered_investment_adviser

SV Health Investors, LLC

Venture Capital

Boston, MA

SV Health Investors is a specialist healthcare fund manager, investing across multiple stages and sectors. Our goal is to transform healthcare one investment at a time.

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:9ac91996-baf4-4b45-873f-0db5bfaf97c0

Data as of Sep 17, 2026 (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built Sep 19, 2026, 5:56 PM UTC and rebuilt at most every 15 minutes.

Relationships: 56
Dated events: 40
On other graphs: 1
Observed: Sep 12, 2026 to Sep 17, 2026
67 observations

Across DFX

same identity by shared identifier, citation, or a bridge measured by hand

RIA / Wealth Managementidentity

SV HEALTH INVESTORS, LLC

Registered adviser · shared crd

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Funds: 24
Vintages: 2009 to 2023
Reported GAV: $962Mgross asset value on Form ADV; never dry powder
Regulatory AUM: $1.1B
Funds with fundraising evidence: 0derived
Investments: 11
Portfolio companies: 11
Investments, 12m: 11
Partner-attributed: 0
People: 11
Investment professionals: 9derived
Co-investors: 0derived
LP relationships: 0
Stated sectors: healthcare,biotech,medtechas stated by the firm
Stated stages: growth
Stated geography: boston,global,uk,united states,usa
Latest Form D: Nov 5, 2024
Latest ADV filing: Mar 31, 2026
Website: svhealthinvestors.com

Funds

Fund	Vintage	Lifecycle	Form D sold	GAV
Sv7 Growth Fund Strategic Partners, L.P.	2023	Active deployment	$0	$9.4M
SV Life Sciences Fund IV Cf, L.P.	2022	Active deployment	n/a	$400M
Medtech Convergence Fund, L.P.	2019	Mature	$0	$31.9M
Sv7 Growth Fund, L.P.	2019	Mature	$91.3M	$80.0M
Life Sciences Fund VI Strategic Partners, L.P.	2017	Harvest	$13.1M	$13.7M
SV Life Sciences Fund VI, L.P.	2015	Harvest	$274M	$260M
SV Life Sciences Fund V Strategic Partners, L.P.	2010	Harvest	$10.6M	$3.3M
SV Life Sciences Fund V, L.P.	2009	Harvest	$407M	$129M
International Life Sciences Fund III (lp2), L.P.	n/a	Wound down	n/a	$4.0M
Schroder Ventures International Life Sciences Fund II L.p.1	n/a	Wound down	n/a	$0
SV7 Plus Growth Fund, L.P.	n/a	Unknown	$0	n/a
Schroder Ventures International Life Sciences Fund II Co-Investment Scheme	n/a	Wound down	n/a	$0
Schroder Ventures International Life Sciences Fund II L.p.2	n/a	Wound down	n/a	$0
Schroder Ventures International Life Sciences Fund Trust	n/a	Wound down	n/a	$0
Schroder Ventures International Life Sciences Fund L.p.1	n/a	Wound down	n/a	$0
International Life Sciences Fund III (lp1), L.P.	n/a	Unknown	n/a	$23.9M
SV Life Sciences Fund IV, L.P.	n/a	Unknown	n/a	$9.5M
SV Life Sciences Fund IV Strategic Partners, L.P.	n/a	Unknown	n/a	$264,036
Schroder Ventures International Life Sciences Fund II L.p.3	n/a	Wound down	n/a	$0
Schroder Ventures International Life Sciences Fund II Strategic Partners, L.P.	n/a	Wound down	n/a	$0
Schroder Ventures International Life Sciences Fund L.p.2	n/a	Wound down	n/a	$0
International Life Sciences Fund III Strategic Partners, L.P.	n/a	Unknown	n/a	$419,549
Schroder Ventures International Life Sciences Fund Co-Investment Scheme	n/a	Wound down	n/a	$0
International Life Sciences Fund III Co-Investment, L.P.	n/a	Unknown	n/a	$574,262

Investments

round size is never this investor's check

Company	State	Stage	Round size	Partner	Attribution	Observed
SV7+ Growth Fund	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Dementia Discovery Fund-2	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
SV Biotech Crossover Opportunities Fund	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
SV7 Impact Medicine Fund	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Dementia Discovery Fund-1	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
SV Life Sciences Funds 5-6	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
SV Fund IV Continuation Fund	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
SV Life Sciences Funds 3-4	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Ether	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Conscience Creative	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
SV8 Biotech Fund	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026

Co-investors

pairs come only from shared rounds and listings

Investor	Co-investor	Shared deals	Shared companies	Last observed	Strength
Abingworth LLP	SV Health Investors	1	1	Sep 16, 2026	One time

Relationships

Member of firm (1)

← SV Health Managers LLPFirmSame registered website
inferenceForm ADV

Invested in (11)

→ SV8 Biotech FundCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Conscience CreativeCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ EtherCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ SV Life Sciences Funds 3-4CompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ SV Fund IV Continuation FundCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ SV Life Sciences Funds 5-6CompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Dementia Discovery Fund-1CompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ SV7 Impact Medicine FundCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ SV Biotech Crossover Opportunities FundCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Dementia Discovery Fund-2CompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ SV7+ Growth FundCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site

Employs (18)

→ Ddf SabPersonInvestment Team
factThe subject's own site
→ Healthcare GrowthPersonPortfolio
factThe subject's own site
→ Paul Arthur LaviolettePersonManaging Partner And Chief Operating Officer
Jan 1, 2014 to presentfactForm ADV
→ Brent Michael FaduskiPersonChief Financial Officer And Chief Compliance Officer
Jan 1, 2018 to presentfactForm ADV
→ Catherine Elizabeth BinghamPersonManaging Partner
Jan 1, 2006 to presentfactForm ADV
→ Michael Jay RossPersonManaging Partner
Jan 1, 2006 to presentfactForm ADV
→ Eugene Dubose HillPersonManaging Partner
Jan 1, 2006 to presentfactForm ADV
→ Michael Hart BalmuthPersonManaging Partner
Jan 1, 2018 to presentfactForm ADV
→ Nikola Nmn TrbovicPersonManaging Partner
Jan 1, 2024 to presentfactForm ADV
→ Thomas Joseph FlynnPersonManaging Partner
Jan 1, 2014 to presentfactForm ADV
→ Greg a MaddenPersonManaging Partner
Jan 1, 2021 to presentfactForm ADV
→ Houman AshrafianPersonManaging Partner
Jan 1, 2019 to Mar 28, 2024inferenceForm ADV
→ Dana Keith O'BrienPersonGeneral Counsel And Chief Compliance Officer
Apr 1, 2019 to Mar 31, 2022inferenceForm ADV
→ Darren Michael BlackPersonClass A Member
Jan 1, 2013 to Sep 11, 2013inferenceForm ADV
→ Lutz Burkhard GiebelPersonClass A Member
Jan 1, 2006 to Feb 4, 2014inferenceForm ADV
→ David Bruce MilnePersonClass A Member
Jan 1, 2006 to Jun 30, 2017inferenceForm ADV
→ James Michael GarveyPersonClass A Member
Jan 1, 2006 to Mar 29, 2019inferenceForm ADV
→ Denise Warner MarksPersonChief Compliance Officer And Chief Administrative Partner
Jan 1, 2006 to May 29, 2019inferenceForm ADV

Manages (26)

→ Schroder Ventures International Life Sciences Fund L.p.1FundVenture Capital Fund
Mar 30, 2012 to presentfactForm ADV
→ Dementia Discovery LPFundVenture Capital Fund
Mar 30, 2016 to presentfactForm ADV
→ DDF Parallel LLPFundVenture Capital Fund
Jun 30, 2017 to presentfactForm ADV
→ Schroder Ventures International Life Sciences Fund Co-Investment SchemeFundVenture Capital Fund
Mar 30, 2012 to presentfactForm ADV
→ Schroder Ventures International Life Sciences Fund II L.p.3FundVenture Capital Fund
Mar 30, 2012 to presentfactForm ADV
→ Schroder Ventures International Life Sciences Fund II L.p.2FundVenture Capital Fund
Mar 30, 2012 to presentfactForm ADV
→ Schroder Ventures International Life Sciences Fund L.p.2FundVenture Capital Fund
Mar 30, 2012 to presentfactForm ADV
→ Schroder Ventures International Life Sciences Fund II Strategic Partners, L.P.FundVenture Capital Fund
Mar 30, 2012 to presentfactForm ADV
→ Schroder Ventures International Life Sciences Fund II Co-Investment SchemeFundVenture Capital Fund
Mar 30, 2012 to presentfactForm ADV
→ Schroder Ventures International Life Sciences Fund II L.p.1FundVenture Capital Fund
Mar 30, 2012 to presentfactForm ADV
→ SV7 Plus Growth Fund, L.P.FundInferred from address
inferenceForm D
→ SV Life Sciences Fund VI, L.P.FundVenture Capital Fund
Mar 30, 2016 to presentfactForm ADV
→ Medtech Convergence Fund, L.P.FundVenture Capital Fund
Mar 29, 2019 to presentfactForm ADV
→ Sv7 Growth Fund, L.P.FundVenture Capital Fund
Mar 29, 2019 to presentfactForm ADV
→ SV Life Sciences Fund IV Cf, L.P.FundVenture Capital Fund
Mar 31, 2022 to presentfactForm ADV
→ Sv7 Growth Fund Strategic Partners, L.P.FundVenture Capital Fund
Mar 30, 2023 to presentfactForm ADV
→ Life Sciences Fund VI Strategic Partners, L.P.FundVenture Capital Fund
Jun 30, 2017 to presentfactForm ADV
→ SV Life Sciences Fund V, L.P.FundVenture Capital Fund
Mar 30, 2012 to presentfactForm ADV
→ SV Life Sciences Fund V Strategic Partners, L.P.FundVenture Capital Fund
Mar 30, 2012 to presentfactForm ADV
→ SV Life Sciences Fund IV, L.P.FundVenture Capital Fund
Mar 30, 2012 to presentfactForm ADV
→ SV Life Sciences Fund IV Strategic Partners, L.P.FundVenture Capital Fund
Mar 30, 2012 to presentfactForm ADV
→ International Life Sciences Fund III (lp1), L.P.FundVenture Capital Fund
Mar 30, 2012 to presentfactForm ADV
→ International Life Sciences Fund III (lp2), L.P.FundVenture Capital Fund
Mar 30, 2012 to presentfactForm ADV
→ International Life Sciences Fund III Co-Investment, L.P.FundVenture Capital Fund
Mar 30, 2012 to presentfactForm ADV
→ International Life Sciences Fund III Strategic Partners, L.P.FundVenture Capital Fund
Mar 30, 2012 to presentfactForm ADV
→ Schroder Ventures International Life Sciences Fund TrustFundVenture Capital Fund
Mar 30, 2012 to presentfactForm ADV

Dated events

24 bookkeeping events (roster, classification and holdings changes) folded below

Occurred
Mar 28, 2024
Person left
Houman Ashrafian (Managing Partner) no longer on Schedule A of SV Health Investors, LLC
Form ADVobserved 7 days ago
Occurred
Jan 1, 2024
Person joined
Nikola Nmn Trbovic joined Schedule A of SV Health Investors, LLC as Managing Partner
Form ADVobserved 7 days ago
Occurred
Mar 31, 2022
Person left
Dana Keith O'Brien (General Counsel And Chief Compliance Officer) no longer on Schedule A of SV Health Investors, LLC
Form ADVobserved 7 days ago
Occurred
Jan 1, 2021
Person joined
Greg a Madden joined Schedule A of SV Health Investors, LLC as Managing Partner
Form ADVobserved 7 days ago
Occurred
May 29, 2019
Person left
Denise Warner Marks (Chief Compliance Officer And Chief Administrative Partner) no longer on Schedule A of SV Health Investors, LLC
Form ADVobserved 7 days ago
Occurred
Apr 1, 2019
Person joined
Dana Keith O'Brien joined Schedule A of SV Health Investors, LLC as General Counsel And Chief Compliance Officer
Form ADVobserved 7 days ago
Occurred
Mar 29, 2019
Person left
James Michael Garvey (Class A Member) no longer on Schedule A of SV Health Investors, LLC
Form ADVobserved 7 days ago
Occurred
Jan 1, 2019
Person joined
Houman Ashrafian joined Schedule A of SV Health Investors, LLC as Managing Partner
Form ADVobserved 7 days ago
Occurred
Jan 1, 2019
Person joined
Michael Hart Balmuth joined Schedule A of SV Health Investors, LLC as Class A Member
Form ADVobserved 7 days ago
Occurred
Jun 30, 2017
Person left
David Bruce Milne (Class A Member) no longer on Schedule A of SV Health Investors, LLC
Form ADVobserved 7 days ago
Occurred
Feb 4, 2014
Person left
Lutz Burkhard Giebel (Class A Member) no longer on Schedule A of SV Life Sciences Advisers, LLC
Form ADVobserved 7 days ago
Occurred
Jan 1, 2014
Person joined
Thomas Joseph Flynn joined Schedule A of SV Life Sciences Advisers, LLC as Class A Member
Form ADVobserved 7 days ago
Occurred
Jan 1, 2014
Person joined
Paul Arthur Laviolette joined Schedule A of SV Life Sciences Advisers, LLC as Class A Member
Form ADVobserved 7 days ago
Occurred
Sep 11, 2013
Person left
Darren Michael Black (Class A Member) no longer on Schedule A of SV Life Sciences Advisers, LLC
Form ADVobserved 7 days ago
Occurred
Jan 1, 2013
Person joined
Darren Michael Black joined Schedule A of SV Life Sciences Advisers, LLC as Class A Member
Form ADVobserved 7 days ago
Occurred
Mar 30, 2012
Adviser's first ADV filing
SV Life Sciences Advisers, LLC first filed Form ADV (ERA, venture capital fund adviser exemption)
Form ADVobserved 7 days ago

Show 24 bookkeeping events

Occurred
Mar 30, 2023
Schroder Ventures International Life Sciences Fund II L.p.1 no longer reported on Form ADV by SV Health Investors, LLC
Occurred
Mar 30, 2023
Schroder Ventures International Life Sciences Fund II L.p.2 no longer reported on Form ADV by SV Health Investors, LLC
Occurred
Mar 30, 2023
Schroder Ventures International Life Sciences Fund II L.p.3 no longer reported on Form ADV by SV Health Investors, LLC
Occurred
Mar 30, 2023
Sv7 Growth Fund Strategic Partners, L.P. first reported on Form ADV by SV Health Investors, LLC (Venture Capital Fund), GAV $12,816,879
Occurred
Mar 30, 2023
Schroder Ventures International Life Sciences Fund II Strategic Partners, L.P. no longer reported on Form ADV by SV Health Investors, LLC
Occurred
Mar 30, 2023
Schroder Ventures International Life Sciences Fund II Co-Investment Scheme no longer reported on Form ADV by SV Health Investors, LLC
Occurred
Mar 31, 2022
SV Life Sciences Fund IV Cf, L.P. first reported on Form ADV by SV Health Investors, LLC (Venture Capital Fund), GAV $420,228,470
Occurred
Mar 29, 2019
Dementia Discovery LP no longer reported on Form ADV by SV Health Investors, LLC
Occurred
Mar 29, 2019
DDF Parallel LLP no longer reported on Form ADV by SV Health Investors, LLC
Occurred
Mar 29, 2019
Medtech Convergence Fund, L.P. first reported on Form ADV by SV Health Investors, LLC (Venture Capital Fund)
Occurred
Mar 29, 2019
Sv7 Growth Fund, L.P. first reported on Form ADV by SV Health Investors, LLC (Venture Capital Fund)
Occurred
Mar 29, 2018
SV Life Sciences Fund VI Strategic Partners, L.P. no longer reported on Form ADV by SV Health Investors, LLC
Occurred
Jun 30, 2017
Life Sciences Fund VI Strategic Partners, L.P. first reported on Form ADV by SV Health Investors, LLC (Venture Capital Fund), GAV $13,262,626
Occurred
Jun 30, 2017
DDF Parallel LLP first reported on Form ADV by SV Health Investors, LLC (Venture Capital Fund), GAV $18,750,000
Occurred
Jun 30, 2017
SV Life Sciences Fund VI Strategic Partners, L.P. first reported on Form ADV by SV Health Investors, LLC (Venture Capital Fund), GAV $13,262,626
Occurred
Mar 30, 2017
Schroder Ventures International Life Sciences Fund Co-Investment Scheme no longer reported on Form ADV by SV Life Sciences Advisers, LLC
Occurred
Mar 30, 2017
Schroder Ventures International Life Sciences Fund L.p.2 no longer reported on Form ADV by SV Life Sciences Advisers, LLC
Occurred
Mar 30, 2017
Schroder Ventures International Life Sciences Fund L.p.1 no longer reported on Form ADV by SV Life Sciences Advisers, LLC
Occurred
Mar 30, 2017
Schroder Ventures International Life Sciences Fund Trust no longer reported on Form ADV by SV Life Sciences Advisers, LLC
Occurred
Mar 30, 2016
SV Life Sciences Fund VI, L.P. first reported on Form ADV by SV Life Sciences Advisers, LLC (Venture Capital Fund), GAV $208,612,651
Occurred
Mar 30, 2016
Dementia Discovery LP first reported on Form ADV by SV Life Sciences Advisers, LLC (Venture Capital Fund), GAV $103,083,652
Occurred
Mar 31, 2015
International Life Sciences Fund III (lp2), L.P. no longer reported on Form ADV by SV Life Sciences Advisers, LLC
Occurred
Mar 30, 2012
Schroder Ventures International Life Sciences Fund L.p.1 first reported on Form ADV by SV Life Sciences Advisers, LLC (Venture Capital Fund), GAV $4,077,654
Occurred
Mar 30, 2012
SV Life Sciences Fund V Strategic Partners, L.P. first reported on Form ADV by SV Life Sciences Advisers, LLC (Venture Capital Fund), GAV $12,904,755

Who to call

the organisation, the role and the published line, with the filing or website that published it; revealed to signed-in accounts

The firm's published line

Revealable: 1 business phone (Form ADV), 2 websites (Form ADV), 2 work emails (firm website) · as of 2026-09-17

Also named here, with no published line of their own (reach them through the firm): Ddf Sab (Investment Team), Healthcare Growth (Portfolio), Paul Arthur Laviolette (Managing Partner And Chief Operating Officer), Brent Michael Faduski (Chief Financial Officer And Chief Compliance Officer), Catherine Elizabeth Bingham (Managing Partner), Michael Jay Ross (Managing Partner), Eugene Dubose Hill (Managing Partner), Michael Hart Balmuth (Managing Partner), Nikola Nmn Trbovic (Managing Partner), Thomas Joseph Flynn (Managing Partner), Greg a Madden (Managing Partner).

Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan

Provenance